ABBOTT LABORATORIES (1ABT.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ABT - US0028241000 - Common Stock
107.82 EUR
-1.12 (-1.03%)
Taking everything into account, 1ABT scores 6 out of 10 in our fundamental rating. 1ABT was compared to 65 industry peers in the Health Care Equipment & Supplies industry. 1ABT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ABT is quite expensive at the moment. It does show a decent growth rate. With these ratings, 1ABT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
1ABT had positive earnings in the past year.
In the past year 1ABT had a positive cash flow from operations.
Each year in the past 5 years 1ABT has been profitable.
1ABT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 16.60%, 1ABT belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
With an excellent Return On Equity value of 27.43%, 1ABT belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
The Return On Invested Capital of 1ABT (9.90%) is better than 78.46% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ABT is in line with the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 9.9% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
1ABT's Profit Margin of 31.88% is amongst the best of the industry. 1ABT outperforms 98.46% of its industry peers.
In the last couple of years the Profit Margin of 1ABT has grown nicely.
Looking at the Operating Margin, with a value of 18.29%, 1ABT is in the better half of the industry, outperforming 73.85% of the companies in the same industry.
1ABT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 56.19%, 1ABT is in line with its industry, outperforming 49.23% of the companies in the same industry.
1ABT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
1ABT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 1ABT has about the same amount of shares outstanding.
The number of shares outstanding for 1ABT has been reduced compared to 5 years ago.
1ABT has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.79 indicates that 1ABT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.79, 1ABT belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
1ABT has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
The Debt to FCF ratio of 1ABT (1.87) is better than 81.54% of its industry peers.
1ABT has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
1ABT has a Debt to Equity ratio of 0.23. This is in the better half of the industry: 1ABT outperforms 67.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.79 |
ROIC/WACC1.18
WACC8.41%
2.3 Liquidity
A Current Ratio of 1.70 indicates that 1ABT should not have too much problems paying its short term obligations.
1ABT's Current ratio of 1.70 is in line compared to the rest of the industry. 1ABT outperforms 52.31% of its industry peers.
A Quick Ratio of 1.24 indicates that 1ABT should not have too much problems paying its short term obligations.
1ABT has a Quick ratio of 1.24. This is comparable to the rest of the industry: 1ABT outperforms 55.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
1ABT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.40%, which is quite good.
Measured over the past 5 years, 1ABT shows a small growth in Earnings Per Share. The EPS has been growing by 7.59% on average per year.
Looking at the last year, 1ABT shows a small growth in Revenue. The Revenue has grown by 6.37% in the last year.
The Revenue has been growing slightly by 5.63% on average over the past years.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
3.2 Future
The Earnings Per Share is expected to grow by 9.89% on average over the next years. This is quite good.
Based on estimates for the next years, 1ABT will show a small growth in Revenue. The Revenue will grow by 7.22% on average per year.
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.89%
Revenue Next Year6.44%
Revenue Next 2Y7.19%
Revenue Next 3Y7.32%
Revenue Next 5Y7.22%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
1ABT is valuated quite expensively with a Price/Earnings ratio of 25.49.
Compared to the rest of the industry, the Price/Earnings ratio of 1ABT indicates a somewhat cheap valuation: 1ABT is cheaper than 64.62% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.57. 1ABT is around the same levels.
A Price/Forward Earnings ratio of 22.17 indicates a rather expensive valuation of 1ABT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ABT is on the same level as its industry peers.
1ABT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.49 | ||
| Fwd PE | 22.17 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1ABT.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ABT indicates a somewhat cheap valuation: 1ABT is cheaper than 63.08% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.95 | ||
| EV/EBITDA | 20.26 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 1ABT may justify a higher PE ratio.
PEG (NY)2.23
PEG (5Y)3.36
EPS Next 2Y10.8%
EPS Next 3Y10.58%
5. Dividend
5.1 Amount
1ABT has a Yearly Dividend Yield of 2.02%.
Compared to an average industry Dividend Yield of 1.03, 1ABT pays a bit more dividend than its industry peers.
1ABT's Dividend Yield is comparable with the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
5.2 History
The dividend of 1ABT is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1ABT pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1ABT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
BIT:1ABT (12/16/2025, 7:00:00 PM)
107.82
-1.12 (-1.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners81.17%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap187.48B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts79.43
Price Target126.5 (17.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
Yearly Dividend1.88
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0.48%
EPS NQ rev (3m)0.84%
EPS NY rev (1m)0.15%
EPS NY rev (3m)-0.1%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.49 | ||
| Fwd PE | 22.17 | ||
| P/S | 5.04 | ||
| P/FCF | 31.95 | ||
| P/OCF | 24.23 | ||
| P/B | 4.34 | ||
| P/tB | 10.33 | ||
| EV/EBITDA | 20.26 |
EPS(TTM)4.23
EY3.92%
EPS(NY)4.86
Fwd EY4.51%
FCF(TTM)3.37
FCFY3.13%
OCF(TTM)4.45
OCFY4.13%
SpS21.39
BVpS24.86
TBVpS10.43
PEG (NY)2.23
PEG (5Y)3.36
Graham Number48.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 9.9% | ||
| ROICexc | 11.13% | ||
| ROICexgc | 21.33% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.79 |
F-Score7
WACC8.41%
ROIC/WACC1.18
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.89%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.44%
Revenue Next 2Y7.19%
Revenue Next 3Y7.32%
Revenue Next 5Y7.22%
EBIT growth 1Y15.18%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.08%
EBIT Next 3Y15.42%
EBIT Next 5Y13.66%
FCF growth 1Y53.98%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y39.24%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%
ABBOTT LABORATORIES / 1ABT.MI FAQ
What is the fundamental rating for 1ABT stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1ABT.MI.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 3 / 10 to ABBOTT LABORATORIES (1ABT.MI). This can be considered as Overvalued.
Can you provide the profitability details for ABBOTT LABORATORIES?
ABBOTT LABORATORIES (1ABT.MI) has a profitability rating of 7 / 10.
What is the valuation of ABBOTT LABORATORIES based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (1ABT.MI) is 25.49 and the Price/Book (PB) ratio is 4.34.
Can you provide the financial health for 1ABT stock?
The financial health rating of ABBOTT LABORATORIES (1ABT.MI) is 7 / 10.